Literature DB >> 20643357

Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes.

Viola Hélène Lobert1, Andreas Brech, Nina Marie Pedersen, Jørgen Wesche, Angela Oppelt, Lene Malerød, Harald Stenmark.   

Abstract

Cell migration requires endocytosis and recycling of integrins, but it is not known whether degradation of these membrane proteins is involved. Here we demonstrate that in migrating cells, a fraction of the endocytosed fibronectin receptor, alpha 5 beta 1 integrin, is sorted into multivesicular endosomes together with fibronectin and degraded in lysosomes. This sorting requires fibronectin-induced ubiquitination of the alpha 5 subunit, and the activity of the endosomal sorting complex required for transport (ESCRT) machinery, which interacts with alpha 5 beta 1 integrin. Importantly, we demonstrate that both alpha 5 ubiquitination and ESCRT functions are required for proper migration of fibroblasts. We propose that ligand-mediated degradation of alpha 5 beta 1 integrin via the ESCRT pathway is required in order to prevent endosomal accumulation of ligand-bound integrins that might otherwise form nonproductive adhesion sites. Fibronectin and alpha 5 beta 1 integrin therefore are trafficked to lysosomes in a similar way to growth factors and their receptors. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643357     DOI: 10.1016/j.devcel.2010.06.010

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  110 in total

Review 1.  Shaping development with ESCRTs.

Authors:  Tor Erik Rusten; Thomas Vaccari; Harald Stenmark
Journal:  Nat Cell Biol       Date:  2011-12-22       Impact factor: 28.824

2.  Cell migration: ESCRTing integrin degradation.

Authors:  Iley Ozerlat
Journal:  Nat Rev Mol Cell Biol       Date:  2010-08-18       Impact factor: 94.444

Review 3.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

Review 4.  Ubiquitin-dependent sorting in endocytosis.

Authors:  Robert C Piper; Ivan Dikic; Gergely L Lukacs
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

Review 5.  Integrin inactivators: balancing cellular functions in vitro and in vivo.

Authors:  Daniel Bouvard; Jeroen Pouwels; Nicola De Franceschi; Johanna Ivaska
Journal:  Nat Rev Mol Cell Biol       Date:  2013-05-30       Impact factor: 94.444

6.  Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src.

Authors:  Yan Gong; Xuehui Yang; Qing He; Lindsey Gower; Igor Prudovsky; Calvin P H Vary; Peter C Brooks; Robert E Friesel
Journal:  Angiogenesis       Date:  2013-08-17       Impact factor: 9.596

7.  Disruption of the coxsackievirus and adenovirus receptor-homodimeric interaction triggers lipid microdomain- and dynamin-dependent endocytosis and lysosomal targeting.

Authors:  Sara Salinas; Charleine Zussy; Fabien Loustalot; Daniel Henaff; Guillermo Menendez; Penny E Morton; Maddy Parsons; Giampietro Schiavo; Eric J Kremer
Journal:  J Biol Chem       Date:  2013-11-22       Impact factor: 5.157

8.  Autophagy modulates cell migration and β1 integrin membrane recycling.

Authors:  Véronique Tuloup-Minguez; Ahmed Hamaï; Anne Greffard; Valérie Nicolas; Patrice Codogno; Joëlle Botti
Journal:  Cell Cycle       Date:  2013-09-09       Impact factor: 4.534

9.  Class III phosphatidylinositol-3-OH kinase controls epithelial integrity through endosomal LKB1 regulation.

Authors:  Fergal O'Farrell; Viola Hélène Lobert; Marte Sneeggen; Ashish Jain; Nadja Sandra Katheder; Eva Maria Wenzel; Sebastian Wolfgang Schultz; Kia Wee Tan; Andreas Brech; Harald Stenmark; Tor Erik Rusten
Journal:  Nat Cell Biol       Date:  2017-10-30       Impact factor: 28.824

10.  Rab5 activation as a tumor cell migration switch.

Authors:  Pablo Mendoza; Jorge Díaz; Patricio Silva; Vicente A Torres
Journal:  Small GTPases       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.